press release
Nov. 28, 2011, 11:21 a.m. EST
SASKATOON, Saskatchewan, Nov 28, 2011 (BUSINESS WIRE) -- AdeTherapeutics, Inc. received Health Canada approval in November to conduct a double-blind randomized placebo controlled study in 30 patients to test its therapeutic to reduce adhesion (scar tissue) formation following laparoscopic procedure to remove an ectopic pregnancy.
Designed by surgeons, the trial is powered to potentially establish standard of care. The novel mechanism, which modulates normal healing process, is also being studied in other surgical areas of high unmet medical need.
The trial will be conducted at teaching hospitals in Canada with first patient enrolment expected in December 2011.
Click here to read the rest: http://www.marketwatch.com/story/adetherapeutics-inc-health-canada-approves-clinical-trial-for-adhesion-prevention-2011-11-28
Adhesion Related Disorder, ARD, Capps, Abdominal Pain, Adhesions, adhesion-related disorders, complex abdominopelvic and pain syndrome, chronic pelvic pain, hysterectomy. Patient oriented database of information regarding all aspects of internal scar tissue, adhesions.
Showing posts with label ectopic. Show all posts
Showing posts with label ectopic. Show all posts
Wednesday, November 30, 2011
Subscribe to:
Posts (Atom)